» Articles » PMID: 36046756

Peripartum Cardiomyopathy: Characteristics and Outcomes Among Women Seen at a Referral Hospital in Lusaka, Zambia

Overview
Date 2022 Sep 1
PMID 36046756
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Peripartum cardiomyopathy (PPCM) disproportionately affects women of African descent, however knowledge about this disease in African countries is limited.

Objectives: To describe the phenotype of women with PPCM seen at a referral hospital in Zambia and examine outcomes at 6 months.

Methods: A prospective observational study describing characteristics and 6-month outcomes was performed at the University Teaching Hospital Echocardiography Lab in Lusaka, Zambia.

Results: We enrolled 45 participants with PPCM and 38 were seen at 6-month follow up; 3 (7 %) died and 4 (9 %) were lost to follow up. Mean age was 32.9 years (SD:7.0); mean BMI was 25.3 kg/m (SD:4.1), mean parity was 3.4 (SD:2.2) children and twin pregnancies occurred in 4 (9 %). Median time from symptom onset to diagnosis was 60 days (IQR: 1-280). 20 (44 %) reported gestational hypertension and 10 (22 %) reported preeclampsia. Baseline median left ventricular ejection fraction (LVEF) was 36 % (IQR: 11-45), median left ventricular end-diastolic volume (LVEDV) was 150 mL (IQR: 58-229) and 79 % described New York Heart Association (NYHA) functional class IV symptoms. Median LVEF after 6 months was 49 % (IQR: 23-68;  < 0.001) and median LVEDV was 121 mL (IQR: 66-200;  < 0.001). At 6-month follow up 45 % had LVEF ≥ 50 %, 42 % had LVEDV ≤ 106 mL and 1 (3 %) had NYHA functional class IV symptoms.

Conclusions: Hypertension was prevalent in this cohort. Overall mortality rate was low and clinically significant improvements in cardiac parameters were seen in over 40%. Further research is needed to identify and mitigate gaps in diagnosis and management.

Citing Articles

Peripartum cardiomyopathy: a comprehensive and contemporary review.

Sigauke F, Ntsinjana H, Tsabedze N Heart Fail Rev. 2024; 29(6):1261-1278.

PMID: 39348083 PMC: 11455798. DOI: 10.1007/s10741-024-10435-5.


Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature.

Conti N, Ammirati E, Tedeschi A, Dobrev D Int J Cardiol Heart Vasc. 2022; 43:101154.

PMID: 36440376 PMC: 9678833. DOI: 10.1016/j.ijcha.2022.101154.

References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Sliwa K, Petrie M, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson A . Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020; 41(39):3787-3797. PMC: 7846090. DOI: 10.1093/eurheartj/ehaa455. View

3.
Ware J, Seidman J, Arany Z . Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016; 374(26):2601-2. DOI: 10.1056/NEJMc1602671. View

4.
Gentry M, Dias J, Luis A, Patel R, Thornton J, Reed G . African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010; 55(7):654-9. PMC: 3814012. DOI: 10.1016/j.jacc.2009.09.043. View

5.
Bauersachs J, Konig T, van der Meer P, Petrie M, Hilfiker-Kleiner D, Mbakwem A . Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019; 21(7):827-843. DOI: 10.1002/ejhf.1493. View